NeOnc Technologies Holdings, Inc. (NTHI) Stock

NASDAQ: NTHIHealthcare company in the biotechnology industry, based in Calabasas, CA.

NeOnc Technologies stock price chart

NTHI interactive chart →

NTHI stock quote & key statistics

NeOnc Technologies earnings per share

Income →
Earnings per share

NeOnc Technologies revenue & net income

Income →
RevenueNet income

NeOnc Technologies annual financials

Income statement →
Fiscal yearRevenueNet incomeEPS
FY2025$39,990-$62.1M-$3.56
FY2024$83,000-$11.9M-$0.13
FY2023$70,462-$14.9M—
FY2022$20,000-$3.0M—
FY2021$0-$3.4M—

Fiscal year ending December 31. Source: company filings via EODHD.

About NeOnc Technologies Holdings, Inc.

NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trial; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical trials for its oral administration for the treatment of primary brain cancers, such as meningioma, high grade gliomas, glioblastoma, and secondary brain cancers.

The company was formerly known as NAS-ONC, Inc. and changed its name to NeOnc Technologies Holdings, Inc. in 2009. The company was incorporated in 2005 and is headquartered in Calabasas, California.

NeOnc Technologies stock FAQ

What is the NeOnc Technologies stock ticker symbol?

NeOnc Technologies Holdings, Inc. trades on the NASDAQ under the ticker symbol NTHI.

What sector and industry is NeOnc Technologies in?

NeOnc Technologies Holdings, Inc. is classified in the Healthcare sector, Biotechnology industry.

How many employees does NeOnc Technologies have?

NeOnc Technologies Holdings, Inc. has about 5 full-time employees.

What were NeOnc Technologies's revenue and earnings last fiscal year?

NeOnc Technologies reported revenue of $39,990 and net income of -$62.1M in fiscal 2025, with earnings per share of -$3.56. Revenue declined 51.8% from the prior year.

When did NeOnc Technologies go public?

NeOnc Technologies stock began trading on March 26, 2025.

Biotechnology stocks

All Healthcare stocks →